methyl vanillate has been researched along with Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antwerpen, PV; Dubois, J; Dufrasne, F; Gelbcke, M; Ingrassia, L; Kerff, F; Kiss, R; Kornienko, A; Kraus, JL; Lamoral-Theys, D; Lefranc, F; Nève, J; Neven, P; Pirotte, B; Pottier, L; Proutière, F; Wauthoz, N | 1 |
1 other study(ies) available for methyl vanillate and Neoplasms
Article | Year |
---|---|
Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli.
Topics: Apoptosis; Aurora Kinases; Cell Cycle Proteins; Cytostatic Agents; Inhibitory Concentration 50; Neoplasms; Nuclear Proteins; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship; Vanillic Acid | 2010 |